Evidence map›Paper›PMID 31482987›Full record

ArticleArquivos brasileiros de cardiologia2019

Bradycardic and Antiarrhythmic Effects of the D-Limonene in Rats.

Gildenisson Araújo do Nascimento, Diego Santos de Souza, Bruno Santos Lima, Carla Maria Lins de Vasconcelos, Adriano Antunes de Souza Araújo, Aimée Obolari Durço, Lucindo José Quintans-Junior, Jackson Roberto Guedes da Silva Almeida, Aldeída Pereira Oliveira, Valter Joviniano de Santana-Filho and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. D-limonene (5 (one-methyl-four-[1-methylethenyl]) cyclohexane) diminishes CClRedox report : communications in free radical research · 2022
    Article
  6. Molecules (Basel, Switzerland) · 2022
    Review
  7. Can natural products modulate cytokine storm in SARS-CoV2 patients?Biotechnology reports (Amsterdam, Netherlands) · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Terpenoids as Potential Geroprotectors.Antioxidants (Basel, Switzerland) · 2020
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Gildenisson Araújo do NascimentoUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.ORCID 0000-0002-8736-7117
Diego Santos de SouzaUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.ORCID 0000-0002-3508-9776
Bruno Santos LimaUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.
Carla Maria Lins de VasconcelosUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.ORCID 0000-0002-7197-0261
Adriano Antunes de Souza AraújoUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.
Aimée Obolari DurçoUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.
Lucindo José Quintans-JuniorUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.
Jackson Roberto Guedes da Silva AlmeidaUniversidade Federal do Vale do São Franscisco, Petrolina, PE - Brazil.
Aldeída Pereira OliveiraUniversidade Federal do Piauí, Teresina, PI - Brazil.
Valter Joviniano de Santana-FilhoUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.ORCID 0000-0003-1488-0259
André Sales BarretoUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.
Márcio Roberto Viana Dos SantosUniversidade Federal de Sergipe, São Cristóvão, SE - Brazil.ORCID 0000-0002-9458-0370
Universidade Federal de Sergipe · BRUniversidade Federal do Piauí · BRUniversidade Federal do Vale do São Francisco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundD-limonene (DL) is a monoterpene and is the major component in the essential oil of citrus fruit. It presents antihyperglycemic and vasodilatation activities.

objectivesThis study evaluated the cardiovascular effects and potential antiarrhythmic of DL in rats.

methodsHemodynamic and electrocardiographic (ECG) parameters were measured in male Wistar rats, which under anesthesia had been cannulated in the abdominal aorta and lower vena cava and had electrodes subcutaneously implanted. In the in vitro approach, the heart was removed and perfused using the Langendorff technique. The significance level adopted was 5% (p < 0.05).

resultsDL, in doses of 10, 20, and 40 mg/kg (i.v), produced intense and persistent bradycardia associated with hypotension. Bradycardia with prolonged QTc was observed in the ECG in vivo recording. In the in vivo model of arrhythmia induced by Bay K8644, DL (10 mg/kg) decreased the arrhythmia score from 15.33 ± 3.52 to 4.0 ± 2.64 u.a (p < 0.05, n = 4). In isolated perfused hearts, DL (10-3 M) promoted significant reductions in heart rate (from 228.6 ± 8.5 ms to 196.0 ± 9.3 bpm; p < 0.05) and left ventricular development pressure (from 25.2 ± 3.4 to 5.9 ± 1.8 mmHg; n = 5, p < 0.05).

conclusionsDL produces bradycardia and antiarrhythmic activity in rat heart.

Indexed as

AnimalsAnti-Arrhythmia AgentsArrhythmias, CardiacBlood PressureBradycardiaElectrocardiographyHeart RateHemodynamicsHypotensionIsolated Heart PreparationLimoneneMaleModels, AnimalRats, WistarVentricular PressureAnti-Arrhythmia AgentsLimonene

Identifiers

PMID31482987
PMCPMC7020959
OpenAlexW2967578241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.